Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001209191-23-029216

Director acquired 300,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

RIGGS RORY B · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-09 Conversion : show line 1 in the form +300,000 1,756,762 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-09 Conversion : show line 2 in the form LP interests in RPI US Partners 2019, LP −30,000 354,059 D
Loading xslF345X04/doc4.xml…